Telomeres Might Predict Lung Cancer Recurrence
Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.
Personalized medicine – or matching a patient’s tumor with an appropriate treatment – is transforming lung cancer and bringing a measure of hope to patients, according to a review by Eric S. Kim, M.D., and Kishan J. Pandya, M.D., of the James P. Wilmot Cancer Center, published in the journal Expert Opinion on Medical Diagnostics.
8/15/2013 | 1 comment
Autism expert Susan Hyman, M.D., comments on a new study published in this week’s JAMA Pediatrics that found that children born to mothers who had labor induced or augmented were more likely to develop autism.
8/13/2013 | 0 comments
As part of the National Institutes of Health's Centers of Excellence in Influenza Research and Surveillance (CEIRS), URMC scientists John Treanor, M.D., and David Topham, Ph.D., join their peers in calling for more advanced research on the H7N9 bird flu virus that appeared in China earlier this year. In this video, they describe this research and why it’s important.
8/12/2013 | 0 comments
Neurologist Karl Kieburtz, M.D., M.P.H. will be taking over the roles of director of the Clinical and Translational Science Institute and senior associate dean for Clinical Research at the beginning of September.
8/8/2013 | 0 comments
Investigators are widely studying curcumin for possible anti-cancer activity, and now the URMC has discovered that it also helps to reduce peeling, weepy, skin damage during radiation treatment for breast cancer.
8/7/2013 | 0 comments